- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LGVN
Recent news which mentions LGVN
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
From Benzinga
Why Is Longeveron (LGVN) Stock Up 30% Today?
May 09, 2023
From InvestorPlace
Longeveron Doses First Patient In Phase 2 Clinical Trial Of Lomecel-B™ In Japan For Aging-Related Frailty
April 20, 2023
Tickers
LGVN
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
From Benzinga
Earnings Scheduled For March 10, 2023
March 10, 2023
From Benzinga
From InvestorPlace
3 Penny Stocks That Could Rise 500% in 2023
January 13, 2023
From InvestorPlace
From Benzinga
From InvestorPlace
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
From Benzinga
7 trade ideas for next week
October 23, 2022
From AC Investor Blog
How to Find Stocks That Rise 10x
October 10, 2022
From InvestorPlace
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
September 29, 2022
From Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 28, 2022
From Benzinga
From InvestorPlace
From Benzinga
From InvestorPlace
Why Is Longeveron (LGVN) Stock on the Move Today?
August 31, 2022
From InvestorPlace
Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022
Tickers
LGVN
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Product Gets US FDA Fast Track Designation For Treatment Of Hypoplastic Left Heart Syndrome in Infants
August 31, 2022
Tickers
LGVN
From Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
From Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 24, 2022
From Benzinga
Earnings Scheduled For August 12, 2022
August 12, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.